NiraWave nano 780 is a nanoparticulate near-infrared (NIR) fluorescence contrast agent specifically formulated for pre-clinical optical imaging (OI).
It shows strong emission (fluorescence) in the NIR spectral range allowing for an increased tissue penetration. NiraWave nano 780 provides a broad range for excitation within the UV/VIS spectrum.
Upon intravenous injection, NiraWave nano 780 exhibits a prolonged blood circulation time. It is taken up by the reticuloendothelial system (RES) and accumulates in liver and spleen.

Data and images for NiraWave nano 780

Figures

Figure 1

View details
Absorption and emission spectra of NiraWave™ nano 780.

Figure 1

Absorption and emission spectra of NiraWave™ nano 780.

Specifications for NiraWave nano 780

Overview

NiraWave nano 780 is a nanoparticulate near-infrared (NIR) fluorescence contrast agent specifically formulated for pre-clinical optical imaging (OI).
It shows strong emission (fluorescence) in the NIR spectral range allowing for an increased tissue penetration. NiraWave nano 780 provides a broad range for excitation within the UV/VIS spectrum.
Upon intravenous injection, NiraWave nano 780 exhibits a prolonged blood circulation time. It is taken up by the reticuloendothelial system (RES) and accumulates in liver and spleen.

Detailed product information

Applications

NiraWave nano 780 is indicated for use in optical imaging of animals, for example mice, to facilitate the visualization of the vasculature.
Examples include fluorescence angiography.

References for NiraWave nano 780

Publications

  1. Ballou, B. et al. (2004) Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15: 79-86
  2. Gao, X. et al. (2004)
    In vivo
    cancer targeting and imaging with semiconductor quantum dots.
    Nat. Biotechnol. 22(8): 969-976
  3. So, M. K. et al. (2006)
    Self-illuminating quantum dot conjugates for
    in vivo
    imaging.
    Nat. Biotechnol. 24(3): 339-343

Related products for
NiraWave nano 780

2 products available